Archive | Pharmaceutical Systems

RSS feed for this section

Strengthening Registration and Quality Assurance Systems for Generic ARVs, Related Medicines, and Devices in Namibia

In Namibia, USAID has been providing funding for technical assistance in the areas of pharmaceutical management and systems strengthening since 2003. During this period, the Rational Pharmaceutical Management Plus (RPM Plus) and Strengthening Pharmaceutical Systems (SPS) programs were implemented. RPM Plus supported interventions that largely focused on strengthening systems for the antiretroviral therapy (ART) and prevention of mother-to-child transmission of HIV programs. SPS focused on strengthening systems based on World Health Organization (WHO) building blocks, increasing the number of pharmaceutical personnel available for service delivery, strengthening policy coordination, and improving the regulatory functions of the NMRC. SIAPS focuses on further strengthening of regulatory and management systems in the pharmaceutical sector under the governance and health systems strategic area to support HIV and AIDS and other public health services.

Read full story · Comments are closed

Now available: “What Gets Defined, Gets Measured” Webinar Recording

On Wednesday, December 6, SIAPS presented its webinar “What Gets Defined, Gets Measured: Definitions and a Framework for Measuring Pharmaceutical Systems Strengthening.” This webinar defined the terms “pharmaceutical system” and “pharmaceutical systems strengthening” and discussed the identification and piloting of indicators for pharmaceutical systems strengthening and the rationale for undertaking this work. Please find the […]

Read full story · Comments { 0 }

Assessing Sub-National Procurement Practices of Maternal, Newborn, and Child Health Commodities in Kenya

The SIAPS Program works at both the global and country levels to improve pharmaceutical management systems that increase access to quality medicines. SIAPS has developed a methodology to assess sub-national procurement practices. This methodology was used in Kenya to assess county-level procurement practices for essential maternal, newborn, and child health (MNCH) commodities and to study the availability of essential MNCH commodities. The information gathered was used to generate recommendations to strengthen local procurement practices and overall procurement strategies.

Read full story · Comments are closed

Special preview: A new tool to measure pharmaceutical systems strengthening

By Helena Walkowiak and Maura Soucy Brown In SIAPS’ upcoming webinar on defining and measuring pharmaceutical systems strengthening (PSS), we’ll talk briefly about the development of a new tool that SIAPS and its partners are piloting. It’s intended to help the field measure the impact of PSS efforts. Some background on this activity: SIAPS has […]

Read full story · Comments { 0 }

SIAPS Annual Report: Program Year 6

To learn more about SIAPS program activities worldwide, please read our annual report for program year 6.

Read full story · Comments are closed

What Gets Defined, Gets Measured: Definitions and a Framework for Measuring Pharmaceutical Systems Strengthening

SIAPS is presenting its webinar “What Gets Defined, Gets Measured: Definitions and a Framework for Measuring Pharmaceutical Systems Strengthening” on Wednesday, December 6, at 8:00 am EST. Although a variety of tools are available to measure different elements of pharmaceutical systems, few attempts have been made to conceptualize a “pharmaceutical system” as an entity and […]

Read full story · Comments { 0 }

Swaziland Medicine Safety Watch

Inside this issue:

  • Pharmacovigilance in Swaziland
  • Update on 2016-2017 Spontaneous Reporting Systems
  • Medicine Safety Alerts
  • How to Report an ADE
Read full story · Comments are closed

SIAPS Namibia provides technical assistance to revise the National Medicines Policy

SIAPS Namibia staff helped the Pharmaceutical Services Division of the Ministry of Health and Social Services (MOHSS) of Namibia to revise the National Medicines Policy (NMP). The NMP, launched in 1998 and revised in 2012, provides guidelines and development objectives for the country’s pharmaceutical sectors.[1] It provides the framework within which pharmaceutical sector priorities are […]

Read full story · Comments { 0 }

Strengthening Governance in Procurement in Bangladesh

Despite being one of the most densely populated countries in the world, the overall health in Bangladesh has steadily improved over the last 30 years. While the Government of Bangladesh’s efforts have resulted in impressive gains in public health, weaknesses in pharmaceutical management, including logistics and supplies, infrastructure, and the low performance of health care providers, remain obstacles to obtaining access to efficacious medicines and quality health services, particularly for the poor. SIAPS has been working closely with the Ministry of Health and Family Welfare (MOHFW) since 2011 to implement a series of systems strengthening interventions to support the government’s health objectives. Using a systems-based approach, SIAPS catalyzes effective leadership, good governance, and evidence-based decision making to strengthen procurement and supply chain systems.

Read full story · Comments are closed

Developing Better Terms of Reference to Improve the Performance of Pharmaceutical Sector Committees: Case Studies from South Africa

In South Africa, there are numerous governance structures that make crucial decisions about selection, procurement, distribution, and use of medicines, diagnostics, and other pharmaceutical products. A challenge commonly encountered is that critical committees either do not exist or where the committee is in place, it does not function optimally. One of the most underlying causes of poor functioning of committees is the absence of or weak terms of reference (TOR). In 2015, the Affordable Medicines Directorate (AMD) of South Africa’s National Department of Health (NDOH), requested assistance from SIAPS in strengthening the TOR of several national committees, including those involved in selection of medicines for inclusion on the National Essential Medicines List (NEML). SIAPS developed a TOR guidance document that can be used in the development or review of TOR. The purpose of this brief is to share the guidance document and the processes SIAPS and their counterparts followed to develop new and revise existing TOR for three different pharmaceutical sector committees in South Africa.

Read full story · Comments are closed